Screener
BioAmber BIOA Q1 2026 earnings
Reported May 8, 2026 · Before market open
Revenue$2.8MBeat by $1.7M
EPS-$0.52Beat by $0.12
Revenue estimate$1.1M
EPS estimate-$0.64
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.5M
EPS estimate-$0.66
Versus estimates
Revenue
Diluted EPS
FAQ
- When did BioAmber report Q1 2026 earnings?
- BioAmber (BIOA) reported Q1 2026 earnings on May 8, 2026 before market open.
- What were BioAmber's Q1 2026 revenue and EPS?
- BioAmber reported revenue of $2.8M and eps of $-0.52 for Q1 2026.
- Did BioAmber beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $1.1M by $1.7M. EPS beat the consensus estimate of $-0.64 by $0.12.
- How did BioAmber's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 91.0% from $1.5M a year earlier and eps declined 44.4% from $-0.36.
- Where can I find BioAmber's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-213472) and the 10-Q periodic report (0001193125-26-213466) directly on SEC EDGAR. The filing index links above go to sec.gov.
